Navigating Targeted Therapy Access: Innovations...

By João L. Carapinha

November 14, 2025

Evolving Landscape of Targeted Therapies and Access Challenges Expanding targeted therapy access remains a critical challenge amid the pharmaceutical market's shift towa...
Ravulizumab aHUS Reimbursement Reassessment: Navigating New Evidence and Trea...
Global Drug Price Gaps Demand Better Drug Pricing Analysis
Aligning Market Access Strategies with the WHO’s Global Lung Health Resolution
MR-107A-02: Revolutionizing Non-Opioid Pain Management with Viatris’ Breakthr...
South Africa NHI Bill Court Ruling Calls for Scrutiny
Ivonescimab NMPA Approval Signals Breakthrough in Lung Cancer
Enhancing UK Clinical Trials Inclusivity: Opportunities and Innovations in Me...
Cholera Vaccination Campaign Amid Ongoing Outbreak
Promising Dual Immunotherapy for Anaplastic Thyroid Cancer
Advancing Newborn Screening for Sickle Cell Disease in Africa
Thyroid Eye Disease Therapy: Insights from Viridian Therapeutics’ THRIV...
Sanofi’s 340B Rebate Model: A Joint Effort to Reform Drug Pricing Pract...